Shiga, Japan

Toshitake Okui


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshitake Okui

Introduction

Toshitake Okui is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with glucoamylase activity. His work has implications for various applications, including industrial processes and enzyme technology.

Latest Patents

Toshitake Okui holds a patent for polypeptides having glucoamylase activity. This patent describes polypeptides that possess the amino acid sequence represented by SEQ ID NO:6 in the Sequence Listing or an amino acid sequence derived from this sequence through at least one of deletion, addition, insertion, or substitution of one or more amino acids. These polypeptides exhibit thermophilic glucoamylase activity, which is valuable for various industrial applications.

Career Highlights

Throughout his career, Toshitake Okui has been associated with Takara Bio Inc., a company known for its innovative solutions in the life sciences sector. His work at the company has allowed him to focus on research and development in biotechnology, contributing to advancements in enzyme technology.

Collaborations

Toshitake Okui has collaborated with notable colleagues, including Nobuto Koyama and Hikaru Takakura. These collaborations have fostered a productive environment for innovation and research in their respective fields.

Conclusion

Toshitake Okui's contributions to biotechnology, particularly through his patent on glucoamylase-active polypeptides, highlight his role as an influential inventor. His work continues to impact the industry positively, showcasing the importance of innovation in science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…